Pharmaron Beijing Co., Ltd.
300759.SZ
Price:
$29.01
Market Cap:
$42.84B
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, ...[Read more]
Industry
Biotechnology
IPO Date
2019-01-28
Stock Exchange
SHZ
Ticker
300759.SZ
PE Ratio
[33.73]
ROE
[10.70%]
Current Ratio
[1.50]
Dividend Yield
[0.69%]
Enterprise Value
[48.02B]
Dividend History
The ROE as of December 2025 (TTM) for Pharmaron Beijing Co., Ltd. (300759.SZ) is 10.70%
According to Pharmaron Beijing Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 10.70%. This represents a change of 300.51% compared to the average of 2.67% of the last 4 quarters.
Pharmaron Beijing Co., Ltd. (300759.SZ) Historical ROE (quarterly & annually)
How has 300759.SZ ROE performed in the past?
The mean historical ROE of Pharmaron Beijing Co., Ltd. over the last ten years is 15.53%. The current 10.70% ROE has changed -31.12% with respect to the historical average. Over the past ten years (40 quarters), 300759.SZ's ROE was at its highest in in the June 2024 quarter at 6.78%. The ROE was at its lowest in in the March 2020 quarter at 1.29%.
Average
15.53%
Median
13.10%
Minimum
7.05%
Maximum
43.84%
Pharmaron Beijing Co., Ltd. (300759.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of Pharmaron Beijing Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 439.28%
Maximum Annual ROE = 43.84%
Minimum Annual Increase = -77.12%
Minimum Annual ROE = 7.05%
| Year | ROE | Change |
|---|---|---|
| 2024 | 13.17% | 3.27% |
| 2023 | 12.75% | -2.15% |
| 2022 | 13.03% | -20.53% |
| 2021 | 16.40% | 24.07% |
| 2020 | 13.22% | 87.61% |
| 2019 | 7.05% | -50.74% |
| 2018 | 14.30% | 23.74% |
| 2017 | 11.56% | 15.19% |
| 2016 | 10.03% | -77.12% |
| 2015 | 43.84% | 439.28% |
Pharmaron Beijing Co., Ltd. (300759.SZ) Average ROE
How has 300759.SZ ROE performed in the past?
The current ROE of Pharmaron Beijing Co., Ltd. (300759.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.98%
5-year avg
13.71%
10-year avg
15.53%
Pharmaron Beijing Co., Ltd. (300759.SZ) ROE vs. Peers
How is 300759.SZ’s ROE compared to its peers?
Pharmaron Beijing Co., Ltd.’s ROE is less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (15.25%), less than Shanghai Allist Pharmaceuticals Co., Ltd. (33.68%), less than Shanghai RAAS Blood Products Co., Ltd. (5.64%), less than Shenzhen New Industries Biomedical Engineering Co., Ltd. (19.05%), greater than Chongqing Zhifei Biological Products Co., Ltd. (-4.43%), greater than RemeGen Co Ltd (-44.94%), less than Asymchem Laboratories (Tianjin) Co., Ltd. (6.07%), less than Imeik Technology Development Co.,Ltd. (18.98%), less than Beijing Tiantan Biological Products Co., Ltd. (11.56%), less than Beijing Tongrentang Co., Ltd (10.02%),
| Company | ROE | Market cap |
|---|---|---|
| 15.25% | $36.96B | |
| 33.68% | $46.13B | |
| 5.64% | $42.55B | |
| 19.05% | $46.28B | |
| -4.43% | $46.27B | |
| -44.94% | $43.39B | |
| 6.07% | $31.54B | |
| 18.98% | $43.52B | |
| 11.56% | $32.53B | |
| 10.02% | $44.13B |
Build a custom stock screener for Pharmaron Beijing Co., Ltd. (300759.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmaron Beijing Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pharmaron Beijing Co., Ltd. (300759.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pharmaron Beijing Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pharmaron Beijing Co., Ltd.'s ROE?
How is the ROE calculated for Pharmaron Beijing Co., Ltd. (300759.SZ)?
What is the highest ROE for Pharmaron Beijing Co., Ltd. (300759.SZ)?
What is the 3-year average ROE for Pharmaron Beijing Co., Ltd. (300759.SZ)?
What is the 5-year average ROE for Pharmaron Beijing Co., Ltd. (300759.SZ)?
How does the current ROE for Pharmaron Beijing Co., Ltd. (300759.SZ) compare to its historical average?